This study seeks to understand the neural, cognitive and behavioral effects of low doses of psilocybin administered in the form of dried mushroom material (0.5 g of Psilocybe cubensis) consumed in natural settings following a placebo-controlled double-blind experimental design.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Resting state oscillations measured with EEG
Timeframe: 1 week
Attention
Timeframe: 1 week
Inhibitory control
Timeframe: 1 week
Conscious access
Timeframe: 1 week
Visual perception
Timeframe: 1 week
Physical activity
Timeframe: 1 week
Divergent thinking
Timeframe: 1 week
Attention
Timeframe: 1 week
Cognitive flexibility
Timeframe: 1 week
Convergent thinking
Timeframe: 1 week
Convergent thinking
Timeframe: 1 week